SCHEMBL23918052

SCHEMBL23918052

c1ccc(N(c2ccccc2)c2ccc3c(c2)Oc2ccc(N(c4ccccc4)c4ccc5oc6ccccc6c5c4)cc2O3)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.44
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 4/20 0.44
HPGD P15428 4/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
NPC1 O15118 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
RAB9A P51151 2/20 0.44
AHR P35869 2/20 0.40
LMNA P02545 3/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C19 P33261 2/20 0.37
L3MBTL1 Q9Y468 3/20 0.34
CYP3A4 P08684 2/20 0.34
MAOA P21397 2/20 0.34
CYP2C9 P11712 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23918054 0.93 AHR (0.42) MAPTALDH1A1KDM4EHPGDMEN1
SCHEMBL18563237 0.91 AHR (0.41) MAPTALDH1A1KDM4EHPGDMEN1
SCHEMBL12936127 0.91 MAPT (0.52) MAPTALDH1A1KDM4EHPGDMEN1
SCHEMBL10042889 0.91 MAPT (0.52) MAPTALDH1A1KDM4EHPGDMEN1
SCHEMBL26154382 0.91 MAPT (0.52) MAPTALDH1A1KDM4EHPGDMEN1
SCHEMBL14295296 0.91 MAPT (0.52) MAPTALDH1A1KDM4EHPGDMEN1
SCHEMBL15730657 0.91 MAPT (0.52) MAPTALDH1A1KDM4EHPGDMEN1
SCHEMBL23308823 0.91 MAPT (0.52) MAPTALDH1A1KDM4EHPGDMEN1
SCHEMBL18563249 0.90 MAPT (0.42) MAPTALDH1A1KDM4EHPGDMEN1
SCHEMBL19801849 0.87 MAPT (0.49) MAPTALDH1A1KDM4EHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320258-A1 COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320258-A1 COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, OR10J3, OCIAD1 MAPT 3115/4885ALDH1A1 1148/4885KDM4E 1551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.